Maze Therapeutics, Inc. · NASDAQ:MAZE

Bernstein Harold sold 15,000 Maze Therapeutics, Inc. shares (Form 4)

Traded May 14, 2026 · Filed May 18, 2026

On May 14, 2026, Bernstein Harold (President, R&D & CMO) sold 15,000 Maze Therapeutics, Inc. shares at US$26.22 for US$393K under a trading plan, leaving 0 shares. Filed May 18, 2026 (Form 4).

Sold
15,000 shares
Price
US$26.22
Value
US$393K
Holding after
0 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, R&D & CMO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 14, 2026Common StockOption exercise15,000US$10.4215,000Direct
May 14, 2026Common StockSale15,000US$26.220Direct

Source

View original at SEC

Related